Curbing inflammation through endogenous pathways: Focus on melanocortin peptides

International Journal of Inflammation

Volumn 2013, Issue , 2013, Pages

  Ahmed, Tazeen J ^a   Montero Melendez, Trinidad ^a   Perretti, Mauro ^a   Pitzalis, Costantino ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFAMELANOTIDE; ALPHA INTERMEDIN; AP 214; BMS 470539; BREMELANOTIDE; CHEMOKINE; CORTICOTROPIN; CORTISONE; CYTOKINE; CZEN 001; GAMMA INTERMEDIN; HP 228; INTERLEUKIN 10; INTERLEUKIN 6; INTERMEDIN; ME 10501; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PLACEBO; PROOPIOMELANOCORTIN; RM 493; TETRACOSACTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACNE VULGARIS; ACUTE KIDNEY FAILURE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTHRITIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC INFLAMMATION; CLINICAL TRIAL (TOPIC); COLITIS; CONTACT DERMATITIS; DIABETIC NEPHROPATHY; DISEASE MODEL; ERYTHROPOIETIC PROTOPORPHYRIA; FEMALE SEXUAL DYSFUNCTION; GOUT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INFLAMMATION; KIDNEY INJURY; LEUKOCYTE; LUNG INJURY; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SOLAR URTICARIA; SYSTEMIC LUPUS ERYTHEMATOSUS; VITILIGO;

EID: 84878676158     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2013/985815     Document Type: Review

References (80)

1. Bannenberg G. L., Chiang N., Ariel A., Arita M., Tjonahen E., Gotlinger K. H., Hong S., Serhan C. N., Molecular circuits of resolution: formation and actions of resolvins and protectins. Journal of Immunology 2005 174 7 4345 4355 2-s2.0-15444364395 (Pubitemid 40396017)
2. Serhan C. N., Savill J., Resolution of inflammation: the beginning programs the end. Nature Immunology 2005 6 12 1191 1197 2-s2.0-30044449982 10.1038/ni1276 (Pubitemid 43045627)
3. Bellingan G. J., Caldwell H., Howie S. E. M., Dransfield I., Haslett C., In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. Journal of Immunology 1996 157 6 2577 2585 2-s2.0-0030587122 (Pubitemid 126450472)
4. Meagher L. C., Savill J. S., Baker A., Fuller R. W., Haslett C., Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. Journal of Leukocyte Biology 1992 52 3 269 273 2-s2.0-0026746561
5. Hughes J., Johnson R. J., Mooney A., Hugo C., Gordon K., Savill J., Neutrophil fate in experimental glomerular capillary injury in the rat: emigration exceeds in situ clearance by apoptosis. American Journal of Pathology 1997 150 1 223 234 2-s2.0-0031021556 (Pubitemid 27027112)
6. Hench P., Effects of cortisone in the rheumatic diseases. Lancet 1950 2 6634 483 484
7. Hench P. S., Reminiscences of the Nobel Festival, 1950. Mayo Clinic Proceedings 1951 26 23 424 437 2-s2.0-24744441091
8. Taylor W. J., Rajapakse C. N. A., Harris K. A., Harrison A. A., Corkill M. M., Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup. Journal of Rheumatology 1999 26 12 2544 2550 2-s2.0-0032751786
9. Ritter J., Dubin Kerr L., Valeriano-Marcet J., Spiera H., ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. Journal of Rheumatology 1994 21 4 696 699 2-s2.0-0028215678 (Pubitemid 24126767)
10. Brzoska T., Luger T. A., Maaser C., Abels C., Böhm M., α -melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Reviews 2008 29 5 581 602 2-s2.0-49449094104 10.1210/er.2007-0027
11. Vessillier S., Adams G., Montero-Melendez T., Jones R., Seed M., Perretti M., Chernajovsky Y., Molecular engineering of short half-life small peptides (VIP, alphaMSH and gamma3MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics. Annals of the Rheumatic Diseases 2012 71 1 143 149
12. Patel H. B., Bombardieri M., Sampaio A. L. F., D'Acquisto F., Gray M., Grieco P., Getting S. J., Pitzalis C., Perretti M., Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis. FASEB Journal 2010 24 12 4835 4843 2-s2.0-78649749715 10.1096/fj.10-167759
13. Getting S. J., Gibbs L., Clark A. J. L., Flower R. J., Perretti M., POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. Journal of Immunology 1999 162 12 7446 7453 2-s2.0-0033564575 (Pubitemid 29277724)
14. Capsoni F., Ongari A., Colombo G., Turcatti F., Catania A., The synthetic melanocortin (CKPV)2 exerts broad anti-inflammatory effects in human neutrophils. Peptides 2007 28 10 2016 2022 2-s2.0-34548802959 10.1016/j.peptides.2007.08.001 (Pubitemid 47432811)
15. Kelly J. M., Moir A. J. G., Carlson K., Yang Y., MacNeil S., Haycock J. W., Immobilized α -melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor- α stimulated NF- B activity. Peptides 2006 27 2 431 437 2-s2.0-31544470059 10.1016/j.peptides.2005.03.062 (Pubitemid 43162915)
16. Doi K., Hu X., Yuen P. S. T., Leelahavanichkul A., Yasuda H., Kim S. M., Schnermann J., Jonassen T. E. N., Frøkiær J., Nielsen S., Star R. A., AP214, an analogue of α -melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney International 2008 73 11 1266 1274 2-s2.0-43749111585 10.1038/ki.2008.97 (Pubitemid 351693164)
17. Montero-Melendez T., Patel H. B., Seed M., Nielsen S., Jonassen T. E., Perretti M., The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. American Journal of Pathology 2011 179 1 259 269
18. Getting S. J., Di Filippo C., D'Amico M., Perretti M., The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage. European Journal of Pharmacology 2006 532 1-2 138 144 2-s2.0-33644500196 10.1016/j.ejphar.2005.12.023
19. Kang L., McIntyre K. W., Gillooly K. M., Yang Y., Haycock J., Roberts S., Khanna A., Herpin T. F., Yu G., Wu X., Morton G. C., Tuerdi H., Koplowitz B., Walker S. G., Wardwell-Swanson J., Macor J. E., Lawrence R. M., Carlson K. E., A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice. Journal of Leukocyte Biology 2006 80 4 897 904 2-s2.0-33751524332 10.1189/jlb.1204748 (Pubitemid 44835908)
20. Sharma H. S., Neuroprotective effects of neurotrophins and melanocortins in spinal cord injury: an experimental study in the rat using pharmacological and morphological approaches. Annals of the New York Academy of Sciences 2005 1053 407 421 2-s2.0-29744464639 10.1196/annals.1344.036 (Pubitemid 43031122)
21. Chhajlani V., Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochemistry and Molecular Biology International 1996 38 1 73 80 2-s2.0-0029848043 (Pubitemid 26340463)
22. Chhajlani V., Muceniece R., Wikberg J. E., Molecular cloning of a novel human melanocortin receptor. Biochemical and Biophysical Research Communications 1996 218 2 2, article 638 2-s2.0-0009785052
23. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S. J., DelValle J., Yamada T., Molecular cloning of a novel melanocortin receptor. Journal of Biological Chemistry 1993 268 11 8246 8250 2-s2.0-0027456619 (Pubitemid 23120413)
24. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinson C. J., Yamada T., Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochemical and Biophysical Research Communications 1994 200 3 1214 1220 2-s2.0-0028198975 10.1006/bbrc.1994.1580 (Pubitemid 24181781)
25. Gantz I., Yamada T., Tashiro T., Konda Y., Shimoto Y., Miwa H., Trent J. M., Mapping of the gene encoding the melanocortin-1 (α -melanocyte stimulating hormone) receptor (MC1R) to human chromosome 16q24.3 by fluorescence in situ hybridization. Genomics 1994 19 2 394 395 2-s2.0-0028091349 10.1006/geno.1994.1080 (Pubitemid 24059340)
26. Mountjoy K. G., Robbins L. S., Mortrud M. T., Cone R. D., The cloning of a family of genes that encode the melanocortin receptors. Science 1992 257 5074 1248 1251 2-s2.0-0026800892
27. Roselli-Rehfuss L., Mountjoy K. G., Robbins L. S., Mortrud M. T., Low M. J., Tatro J. B., Entwistle M. L., Simerly R. B., Cone R. D., Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proceedings of the National Academy of Sciences of the United States of America 1993 90 19 8856 8860 2-s2.0-0027436690 10.1073/pnas.90.19.8856 (Pubitemid 23306409)
28. Cooray S. N., Clark A. J. L., Melanocortin receptors and their accessory proteins. Molecular and Cellular Endocrinology 2011 331 2 215 221 2-s2.0-78650291491 10.1016/j.mce.2010.07.015
29. Chan L. F., Webb T. R., Chung T. T., Meimaridou E., Cooray S. N., Guasti L., Chapple J. P., Egertová M., Elphick M. R., Cheetham M. E., Metherell L. A., Clark A. J. L., MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proceedings of the National Academy of Sciences of the United States of America 2009 106 15 6146 6151 2-s2.0-65549109322 10.1073/pnas.0809918106
30. Ramachandrappa S., Gorrigan R. J., Clark A. J., Chan L. F., The melanocortin receptors and their accessory proteins. Frontiers in Endocrinology 2013 4 article 9 10.3389/fendo.2013.00009
31. Konda Y., Gantz I., DelValle J., Shimoto Y., Miwa H., Yamada T., Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. Journal of Biological Chemistry 1994 269 18 13162 13166 2-s2.0-0028233234 (Pubitemid 24206079)
32. Blondet A., Doghman M., Rached M., Durand P., Bégeot M., Naville D., Characterization of cell lines stably expressing human normal or mutated EGFP-tagged MC4R. Journal of Biochemistry 2004 135 4 541 546 2-s2.0-2442680073 10.1093/jb/mvh064 (Pubitemid 38660942)
33. Manna S. K., Aggarwal B. B., α -melanocyte-stimulating hormone inhibits the nuclear transcription factor NF- B activation induced by various inflammatory agents. Journal of Immunology 1998 161 6 2873 2880 2-s2.0-0032531035 (Pubitemid 28425709)
34. Mountjoy K. G., Kong P. L., Taylor J. A., Willard D. H., Wilkison W. O., Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiological Genomics 2001 5 1 11 19 2-s2.0-0035819682 (Pubitemid 33675198)
35. Newman E. A., Chai B. X., Zhang W., Li J. Y., Ammori J. B., Mulholland M. W., Activation of the melanocortin-4 receptor mobilizes intracellular free calcium in immortalized hypothalamic neurons1 1 this work was supported by NIH Grants T32CA009672 and RO1DK054032. Journal of Surgical Research 2006 132 2 201 207 2-s2.0-33646103123 10.1016/j.jss.2006.02.003
36. Böhm M., Eickelmann M., Li Z., Schneider S. W., Oji V., Diederichs S., Barsh G. S., Vogt A., Stieler K., Blume-Peytavi U., Luger T. A., Detection of functionally active melanocortin receptors and evidence for an immunoregulatory activity of α -melanocyte-stimulating hormone in human dermal papilla cells. Endocrinology 2005 146 11 4635 4646 2-s2.0-25144443338 10.1210/en.2005-0665 (Pubitemid 41446601)
37. Eves P., Haycock J., Layton C., Wagner M., Kemp H., Szabo M., Morandini R., Ghanem G., García-Borrón J. C., Jiménez-Cervantes C., Mac Neil S., Anti-inflammatory and anti-invasive effects of α -melanocyte-stimulating hormone in human melanoma cells. British Journal of Cancer 2003 89 10 2004 2015 2-s2.0-0346752502 10.1038/sj.bjc.6601349 (Pubitemid 37533283)
38. Elliott R. J., Szabo M., Wagner M. J., Kemp E. H., MacNeil S., Haycock J. W., α -melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. Journal of Investigative Dermatology 2004 122 4 1010 1019 2-s2.0-2342563867 10.1111/j.0022-202X.2004.22404.x (Pubitemid 38581004)
39. Ichiyama T., Campbell I., Furukawa S., Catania A., Lipton J., Autocrine alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human glioma. Journal of Neuroscience Research 1999 58 5 684 689
40. Grässel S., Opolka A., Anders S., Straub R. H., Grifka J., Luger T. A., Böhm M., The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of α -melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components. Arthritis and Rheumatism 2009 60 10 3017 3027 2-s2.0-70349780615 10.1002/art.24846
41. Diano S., New aspects of melanocortin signaling: a role for PRCP in α -MSH degradation. Frontiers in Neuroendocrinology 2011 32 1 70 83 2-s2.0-78651463641 10.1016/j.yfrne.2010.09.001
42. Schiöth H. B., Chhajlani V., Muceniece R., Klusa V., Wikberg J. E. S., Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. Life Sciences 1996 59 10 797 801 2-s2.0-0030564894 10.1016/0024-3205(96)00370-0 (Pubitemid 26258924)
43. Adan R. A. H., Oosterom J., Ludvigsdottir G., Brakke J. H., Burbach J. P. H., Gispen W. H., Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors. European Journal of Pharmacology 1994 269 3 331 337 2-s2.0-0028172962 10.1016/0922-4106(94)90041-8 (Pubitemid 24348049)
44. Pérez-Oliva A. B., Olivares C., Jiménez-Cervantes C., García-Borrón J., Mahogunin ring finger-1 (MGRN1) E3 ubiquitin ligase inhibits signaling from melanocortin receptor by competition with G α s. Journal of Biological Chemistry 2009 284 46 31714 31725 2-s2.0-70450245116 10.1074/jbc.M109.028100
45. Martin L. W., Catania A., Hiltz M. E., Lipton J. M., Neuropeptide α -MSH antagonizes IL-6- and TNF-induced fever. Peptides 1991 12 2 297 299 2-s2.0-0025974407 10.1016/0196-9781(91)90015-H
46. Bhardwaj R. S., Schwarz A., Becher E., Mahnke K., Aragane Y., Schwarz T., Luger T. A., Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes 1. Journal of Immunology 1996 156 7 2517 2521 2-s2.0-0029878041
47. Redondo P., García-Foncillas J., Okroujnov I., Bandrés E., α -MSH regulates interleukin-10 expression by human keratinocytes. Archives of Dermatological Research 1998 290 8 425 428 2-s2.0-0031663807 10.1007/s004030050330 (Pubitemid 28431851)
48. Grabbe S., Bhardwaj R. S., Mahnke K., Simon M. M., Schwarz T., Luger T. A., α -melanocyte-stimulating hormone induces hapten-specific tolerance in mice. Journal of Immunology 1996 156 2 473 478 2-s2.0-0029670721
49. Slominski A., Wortsman J., Luger T., Paus R., Solomon S., Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiological Reviews 2000 80 3 979 1020 2-s2.0-0033946195 (Pubitemid 30452009)
50. Scholzen T. E., Sunderkötter C., Kalden D. H., Brzoska T., Fastrich M., Fisbeck T., Armstrong C. A., Ansel J. C., Luger T. A., α -melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 2003 144 1 360 370 2-s2.0-0037227834 10.1210/en.2002-220651 (Pubitemid 36076126)
51. Raap U., Brzoska T., Sohl S., Päth G., Emmel J., Herz U., Braun A., Luger T., Renz H., α -melanocyte-stimulating hormone inhibits allergic airway inflammation. Journal of Immunology 2003 171 1 353 359 2-s2.0-0038205889 (Pubitemid 36745308)
52. Giuliani D., Ottani A., Minutoli L., Stefano V. D., Galantucci M., Bitto A., Zaffe D., Altavilla D., Botticelli A. R., Squadrito F., Guarini S., Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268. Brain, Behavior, and Immunity 2009 23 6 844 850 2-s2.0-67649836294 10.1016/j.bbi.2009.03.009
53. Zierath D., Tanzi P., Cain K., Shibata D., Becker K., Plasma alpha-melanocyte stimulating hormone predicts outcome in ischemic stroke. Stroke 2011 42 12 3415 3420
54. Chiao H., Kohda Y., McLeroy P., Craig L., Housini I., Star R. A., α -melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. Journal of Clinical Investigation 1997 99 6 1165 1172 2-s2.0-0030978140 (Pubitemid 27142751)
55. Chiao H., Foster S., Thomas R., Lipton J., Star R. A., α -melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. Journal of Clinical Investigation 1996 97 9 2038 2044 2-s2.0-0029958822 (Pubitemid 26143957)
56. Deng J., Hu X., Yuen P. S. T., Star R. A., α -melanocyte- stimulating hormone inhibits lung injury after renal ischemia/reperfusion. American Journal of Respiratory and Critical Care Medicine 2004 169 6 749 756 2-s2.0-1542407041 (Pubitemid 38338928)
57. Adams G., Vessillier S., Dreja H., Chernajovsky Y., Targeting cytokines to inflammation sites. Nature Biotechnology 2003 21 11 1314 1320 2-s2.0-0242353920 10.1038/nbt888 (Pubitemid 37356616)
58. Ceriani G., Diaz J., Murphree S., Catania A., Lipton J. M., The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1994 1 1 28 32 2-s2.0-0028366845
59. Chuang I. C., Jhao C. M., Yang C. H., Chang H. C., Wang C. W., Lu C. Y., Chang Y. J., Lin S. H., Huang P. L., Yang L. C., Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritis. Arthritis Research & Therapy 2004 6 1 R7 R14
60. Capsoni F., Ongari A. M., Reali E., Catania A., Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells. Arthritis Research and Therapy 2009 11 5, article R151 2-s2.0-75649148603 10.1186/ar2827
61. Getting S. J., Gibbs L., Clark A. J. L., Flower R. J., Perretti M., POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. Journal of Immunology 1999 162 12 7446 7453 2-s2.0-0033564575 (Pubitemid 29277724)
62. Getting S. J., Flower R. J., Perretti M., Agonism at melanocortin receptor type 3 on macrophages inhibits neutrophil influx. Inflammation Research 1999 48 supplement 2 S140 S141 2-s2.0-0033397801 (Pubitemid 30020086)
63. Getting S. J., Christian H. C., Flower R. J., Perretti M., Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis and Rheumatism 2002 46 10 2765 2775 2-s2.0-0036822278 10.1002/art.10526 (Pubitemid 36118942)
64. Getting S. J., Christian H. C., Lam C. W., Gavins F. N. E., Flower R. J., Schiöth H. B., Perretti M., Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. Journal of Immunology 2003 170 6 3323 3330 2-s2.0-0347927272 (Pubitemid 36302211)
65. Getting S. J., Lam C. W., Chen A. S., Grieco P., Perretti M., Melanocortin 3 receptors control crystal-induced inflammation. FASEB Journal 2006 20 13 2234 2241 2-s2.0-33845664425 10.1096/fj.06-6339com (Pubitemid 44953853)
66. Getting S. J., Lam C. W., Leoni G., Gavins F. N. E., Grieco P., Perretti M., [D-Trp8]- γ -melanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse). Molecular Pharmacology 2006 70 6 1850 1855 2-s2.0-33751080408 10.1124/mol.106.028878 (Pubitemid 44771900)
67. Hench P. S., The present status of cortisone and ACTH in general medicine. Proceedings of the Royal Society of Medicine 1950 43 10 769 773 2-s2.0-76549224066
68. Hench P. S., Introduction: cortisone and ACTH in clinical medicine. Mayo Clinic Proceedings 1950 25 17 474 476 2-s2.0-76549245288
69. Hench P. S., Kendall E. C., Slocumb C. H., Polley H. F., The antirheumatic effects of cortisone and pituitary ACTH. Transactions & Studies of the College of Physicians of Philadelphia 1950 18 3 95 102 2-s2.0-53649089772
70. Hench P. S., Kendall E. C., Slocumb C. H., Polley H. F., Cortisone, its effects on rheumatoid arthritis, rheumatic fever, and certain other conditions. The Merck Report 1950 59 4 9 14 2-s2.0-17044425116
71. Hench P. S., Kendall E. C., Slocumb C. H., Polley H. F., Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Archivio di Medicina Interna 1950 85 4 545 666 2-s2.0-76549251874
72. Hench P. S., Slocumb C. H., Polley H. F., Kendall E. C., Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases. Journal of the American Medical Association 1950 144 16 1327 1335 2-s2.0-0000078552
73. Catania A., Gerloni V., Procaccia S., Airaghi L., Manfredi M. G., Lomater C., Grossi L., Lipton J. M., The anticytokine neuropeptide alpha-melanocyte- stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation 1994 1 5 321 328 2-s2.0-0028505291
74. Bohm M., Grassel S., Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system from basic to translational research. Endocrine Reviews 2012 33 4 623 651
75. Yoon S. W., Chun J. S., Sung M. H., Kim J. Y., Poo H., α -MSH inhibits TNF- α -induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor B signaling in human chondrosarcoma HTB-94 cells. Osteoarthritis and Cartilage 2008 16 1 115 124 2-s2.0-38349161595 10.1016/j.joca.2007.05.026
76. Kaneva M. K., Kerrigan M. J., Grieco P., Curley G. P., Locke I. C., Getting S. J., Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-alpha activated human C-20/A4 chondrocytes. British Journal of Pharmacology 2012 167 1 67 79
77. Greenfield J. R., Miller J. W., Keogh J. M., Henning E., Satterwhite J. H., Cameron G. S., Astruc B., Mayer J. P., Brage S., See T. C., Lomas D. J., O'Rahilly S., Farooqi I. S., Modulation of blood pressure by central melanocortinergic pathways. New England Journal of Medicine 2009 360 1 44 52 2-s2.0-58249087146 10.1056/NEJMoa0803085
78. Gong R., The renaissance of corticotropin therapy in proteinuric nephropathies. Nature Reviews Nephrology 2012 8 2 122 128
79. Berkovich R., Treatment of acute relapses in multiple sclerosis. Neurotherapeutics 2013 10 1 97 105
80. Polley H. F., Hench P. S., Brunsting L. A., Effects of cortisone and ACTH on psoriatic arthritis. The Journal of Laboratory and Clinical Medicine 1950 36 6 973 974 2-s2.0-76549218886